Marksans Pharma Inc. is recalling over 309 million units of Ibuprofen Tablets and Caplets in 200 mg, 400 mg, 600 mg, and 800 mg strengths. The recall was initiated due to numerous complaints of an unusual odor coming from the medication, which was traced back to deficiencies in Current Good Manufacturing Practice (CGMP) standards. These prescription and over-the-counter medications were manufactured in India and distributed in bulk packs to various repackaging firms before being sent to pharmacies nationwide.
The unusual odor indicates a potential chemical or quality deviation during the manufacturing process. While no specific injuries were reported, consuming medication that fails to meet quality standards could lead to unforeseen adverse health effects or a loss of therapeutic efficacy.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.